Categories

Share:

4bases launches a new website

May 6, 2019

After the renewal of our ISO13485:2016 certification in May, the entry of new products in our pipeline and the opening of new markets, the Swiss supplier of CE IVD certified genetic diagnostic tests 4bases launches today its new website.

Concise but comprehensive, the new 4bases websites has been designed to provide you with the right information at the right place and at the right time. Just like our genetic diagnostic tests are easy to use we wanted our website to be user friendly and always updated.

So, please stay tuned and do not hesitate to provide us with your always precious feedback!

Share:

Categories

More Posts

4bases’paper of The Month – January 2024 – Benchmarking and improving the performance of variant-calling pipelines with RecallME

In the realm of DNA sequencing, both next-generation sequencing (NGS) and third-generation sequencing (TGS) have revolutionized genomics. While NGS dominates current research and clinical applications,

4bases’ paper of The Month – December 2023 – CFTR pharmacological modulators: a great advance in cystic fibrosis management

Cystic Fibrosis (CF) is an inherited disease, typically affecting the lungs, pancreas, liver, skin, and urogenital tract due to mutations in the cystic fibrosis transmembrane

4bases’paper of The Month – November 2023 -Genetic testing and counseling in the management of cardiomyopathy

The European Society of Cardiology presented its new guidelines for the management of cardiomyopathies. They aim to assist healthcare professionals in the accurate diagnosis and

4bases’paper of The Month – October 2023 -Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC)

BRCA1 and BRCA2 stand out as the most well-known genes associated with hereditary breast and ovarian cancer (HBOC). Individuals carrying a pathogenic or likely pathogenic

Powered by Lifency SA © 2025